Alternatively, consider the use of non-opioid analgesics in these patients
Meanwhile, that acetaldehyde hangs out and wreaks havoc: causing inflammation, triggering headaches, and ratcheting up your heart rate
Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a position statement of the Fatty Liver Research Group of the Korean Diabetes Association
Headaches: Frequent tension headaches or migraines are reported by many individuals with fibromyalgia
In multiple sclerosis (MS), a neuroinflammatory disease driven by immune-mediated destruction of myelin-producing oligodendrocytes, CYP51A1 has emerged as a potential therapeutic target
It is recommended that a further dose reduction or alternative therapies be considered for patients with low or absent TPMT activity receiving AZASAN and xanthine oxidase inhibitors because both TPMT and XO inactivation pathways are affected (see CLINICAL PHARMACOLOGY, WARNINGS, PRECAUTIONS: Laboratory Tests and ADVERSE REACTIONS sections)
